A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously

被引:2
|
作者
Mezei, Zoltan A. [1 ]
Tornai, David [1 ]
Foldesi, Roza [1 ]
Madar, Laszlo [1 ]
Sumegi, Andrea [2 ]
Papp, Maria [3 ]
Antal-Szalmas, Peter [1 ]
机构
[1] Univ Debrecen, Fac Med, Dept Lab Med, Nagyerdei Str 98, H-4032 Debrecen, Hungary
[2] Hungarian Acad Sci, HAS UD Vasc Biol & Myocardial Pathophysiol Res Gr, Nagyerdei Str 98, H-4032 Debrecen, Hungary
[3] Univ Debrecen, Fac Med, Dept Internal Med, Div Gastroenterol, Nagyerdei Str 98, H-4032 Debrecen, Hungary
关键词
Fms-like tyrosine kinase 3 (FLT3); Internal tandem duplication (ITD); Deep next generation sequencing (NGS); Analytical validation; INTERNAL TANDEM DUPLICATION; MINIMAL RESIDUAL DISEASE; ACUTE MYELOID-LEUKEMIA; ASSAY; PINDEL;
D O I
10.1016/j.jbiotec.2019.06.305
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Internal tandem duplication (ITD) in the fms-like tyrosine kinase 3 (FLT3) gene is one of the most frequent genetic alteration in acute myeloid leukemia (AML), and it is associated with worse clinical outcome. Not only the presence but also the size, localization and the rate of this variant or the presence of multiple ITDs has prognostic information. The traditional PCR based diagnostic methods cannot provide information about all of these parameters in one assay, however the application of next generation sequencing (NGS) technique can be a reliable solution for this diagnostic problem. In order to evaluate the analytical properties of an NGS-based FLT3-ITD detection assay a quality control sample was prepared from DNA of AML patients containing 19 different FLT3-ITD variants identified by NGS. The higher the total read count was in a certain sample of the NGS run, the more ITD variant types could be detected. The maximal sensitivity of FLT3-ITD detection by NGS technique was as low as 0.007% FLT3-ITD/total allele rate, however, below 0.1% rate, the reproducibility of the quantitation was poor (CV > 25%). DNA pools with several FLT3-ITDs can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation testing several different ITD sequences and rates, simultaneously.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 32 条
  • [1] NGS-Based Monitoring of Measurable Residual Disease in FLT3-ITD Positive Acute Myeloid Leukemia
    Blaette, Tamara J.
    Schmalbrock, Laura K.
    Skambraks, Sabrina
    Cocciardi, Sibylle
    Dolnik, Anna
    Doehner, Konstanze
    Bullinger, Lars
    BLOOD, 2018, 132
  • [2] RNAseq Supplements DNA-Based NGS in Confirmation of FLT3-ITD Harboring a Duplicated Splice Site
    Schwab, T.
    Artymiuk, C.
    Cagle, S.
    Koellner, C.
    Mitchell, A.
    Wang, R.
    Bessonen, K.
    Sosa, C.
    Tandale, P.
    Viswanatha, D.
    He, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S32 - S32
  • [3] Alternative Method of DNA Fragment Analysis for the Detection of CALR and FLT3-ITD Mutations
    Walker, E. S.
    Chung, B. M.
    Greenwood, M. P.
    Hendrickson, H. L.
    Olsen, R. J.
    Thomas, J. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1231 - 1231
  • [4] DNA-PK INHIBITION SENSITIZES FLT3-ITD AML CELLS TO CYTARABINE AND SORAFENIB
    Murray, Heather
    Al Mazi, Juhura
    Kahl, Richard
    Flanagan, Hayley
    Smith, Nathan
    Enjeti, Anoop
    Larsen, Martin
    Verrills, Nicole
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 15 - 16
  • [5] ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells
    Scholl, S
    Müller, R
    Clement, JH
    Loncarevic, IF
    Böhmer, FD
    Höffken, K
    LEUKEMIA RESEARCH, 2006, 30 (05) : 633 - 642
  • [6] FLT3-ITD DNA allelic burden, but not mRNA levels, influences the biological characteristics of AML patients
    Soare, Dan S.
    Radu, Eugen
    Dumitru, Ion
    Arghir, Aurora
    Enache, Cristina
    Bumbea, Horia
    Vladareanu, Ana M.
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2021, 29 (01): : 33 - 41
  • [7] Evaluation of tyrosine kinase inhibitor treatment in patients with FLT3-ITD positive acute myeloid leukemia
    Fleischmann, M.
    Schrenk, K. G.
    Schnetzke, U.
    Hilgendorf, I
    Hochhaus, A.
    Scholl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 50 - 51
  • [8] DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia
    Cucchi, David G. J.
    Vonk, Christian M.
    Rijken, Melissa
    Kavelaars, Francois G.
    Merle, Pauline A.
    Verhoef, Elvira
    Venniker-Punt, Bianca
    Kwidama, Zinia J.
    Gradowska, Patrycja
    Lowenberg, Bob
    Janssen, Jeroen J. W. M.
    Cloos, Jacqueline
    Valk, Peter J. M.
    BLOOD ADVANCES, 2021, 5 (21) : 4476 - 4479
  • [9] T(6;9)-DEK/CAN-Positive Leukemia: Role of FLT3-ITD for the Determination of the Leukemic Phenotype
    Heinssmann, Maria
    Drangmeister, Lena
    Schmid, Katharina
    Keller, Maren
    Serve, Hubert
    Oancea, Claudia
    Ruthardt, Martin
    Bug, Gesine
    BLOOD, 2012, 120 (21)
  • [10] 血浆游离DNA检测FLT3-ITD突变及ITD特征对急性髓细胞白血病诊断的意义
    王楠
    吴丹
    赵乙洁
    赵婧媛
    姜凤全
    袁宏
    临床检验杂志, 2015, 33 (02) : 111 - 114